Tribe Revive CBD Gummies: A Practical Look at Their Role in Daily Wellness
CBD gummy bioavailability variability affects how patients experience therapeutic effects. Understanding dosing consistency and absorption factors is crucial for realistic expectations. This article explores these aspects in daily wellness use.
Nearly 9 in 10 Hospitalized Cannabis Use Disorder Patients Had Medications That Could Potentially Interact With Cannabis
A recent cannabis drug interactions clinical evidence review found that nearly 9 in 10 hospitalized cannabis use disorder patients had medications flagged for potential interactions. Opioid substitution therapies like levomethadone were the most common…
Are Seniors Being Used as CBD Guinea Pigs in CMS Program?
The 2026 cannabis clinical safety of seniors in CMS CBD programs is under scrutiny due to potential drug interactions and unique geriatric considerations. This emerging Medicare policy shift could impact older adults' access to cannabis medicine. Careful…
Cannabis Meets Drug Metabolism: What We Know—and Don’t Know—About Cannabinoids and CYP450 Enzymes
The cannabinoid drug interactions clinical evidence review highlights how cannabinoids like CBD and THC can modulate CYP450 enzymes. This modulation may alter the metabolism of many prescription drugs, raising safety concerns. Understanding these…
Cannabis Users Need More Propofol, But Confounders Cloud the Evidence
Cannabis anesthesia requirements are increasingly relevant as cannabis use rises among surgical patients. This meta-analysis finds cannabis users require more propofol, but confounders like age and tobacco use complicate interpretation. Understanding…
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin mushrooms regulation is lagging behind their mainstream adoption, creating clinical risks. Scientific research on psilocybin remains limited, complicating safe patient care. Clinicians must navigate drug interactions and screening to ensure…
Seniors Are Already Using Cannabis – Policy Needs to Catch Up | GreenState
Cannabis use in seniors is increasingly common despite limited clinical guidelines. Older adults use cannabis primarily for chronic pain, insomnia, and anxiety. Policy needs to catch up to ensure safe and effective use in this population.
Study: Low-Dose CBD Found Safe for People With HIV on Long-Term Antiretroviral Therapy
This study investigates cbd safety hiv patients on long-term antiretroviral therapy. Results indicate low-dose CBD is well tolerated without adverse effects. Understanding cbd safety hiv patients is crucial due to potential drug interactions and immune…
Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
Cannabinoids drug interactions with COVID-19 therapeutics are an emerging clinical concern. Understanding cytochrome P450 enzyme involvement is essential for safe prescribing. Patients should disclose cannabis use when receiving COVID treatments.
PharmDs Explain What Happens When You Mix CBD and Alcohol Together
Pharmacokinetic interactions CBD alcohol can affect how both substances are metabolized in the liver. Patients often combine CBD and alcohol without understanding potential risks. This article highlights clinical effects and safety considerations for…